Electromechanical reshaping uses a small electric potential to temporarily alter the chemical environment inside the cornea, allowing researchers to reshape tissue without incisions in about a minute. The technique, studied by Occidental College chemistry professor Michael Hill and University of California, Irvine professor and surgeon Brian Wong, aims to correct refractive errors like nearsightedness using specialized platinum contact lenses that act as electrodes.
How Electromechanical Reshaping Alters Corneal Tissue
The cornea consists largely of water and structural proteins called collagen, which are held rigidly in place by electrically charged components. When an electric potential is applied to the tissue, it changes the local pH level by making the environment more acidic. This temporary acidity weakens the internal electrical attractions that keep the tissue stiff, creating a brief window where the material becomes moldable.
To harness this chemistry, researchers developed specialized platinum contact lenses that function as molds and electrodes simultaneously. Placed over rabbit eyeballs immersed in a saline solution mimicking natural tears, the platinum lenses apply a controlled electric potential. Within roughly a minute, the corneal curvature shifts to match the mold. Once normal pH levels return, the tissue’s structural interactions lock back into place.
Early Experiments on Simulated Myopia and Cloudiness
Investigators tested the electromechanical reshaping procedure on 12 rabbit eyeballs, targeting 10 of them to simulate myopia, or nearsightedness. The technique successfully altered every treated cornea to reach the intended focusing power. The cells within the treated eyes survived the process because researchers maintained careful control over the pH gradient, avoiding excessive damage while still achieving the desired shape change.
Beyond standard vision correction, tests indicated that the method might reverse chemical-induced corneal cloudiness. Currently, that specific condition requires a complete corneal transplant. If future trials confirm these findings, the approach could address medical pathologies alongside refractive errors like nearsightedness, farsightedness, and astigmatism.
The Path From Accidental Discovery to Clinical Trials
The underlying phenomenon was discovered by accident while Brian Wong was examining living tissues as moldable materials. Despite promising results in isolated rabbit eyes, researchers emphasize that the technique remains in early preclinical stages. The next phase requires detailed animal studies, including tests on living rabbits to verify long-term stability and safety.
Funding from the National Eye Institute of the National Institutes of Health and the John Stauffer Charitable Trust supports the work, though financial uncertainty has slowed progress. Michael Hill notes that a significant road remains before human clinical trials, pointing out that while the method is potentially cheaper and reversible, it must clear extensive safety hurdles first.
Frequently Asked Questions About Corneal Reshaping
How does electromechanical reshaping differ from LASIK?
LASIK uses a specialized laser to permanently cut and remove corneal tissue to change its shape. Electromechanical reshaping uses a small electric potential and a platinum mold to temporarily soften the tissue’s chemical structure, allowing it to be reshaped without cutting or removing any tissue.
What causes the cornea to become moldable during the procedure?
Applying an electric potential lowers the pH inside the collagen-rich tissue, making it temporarily acidic. This acidity weakens the electrical attractions holding the collagen structure rigid, making the cornea easy to mold until its normal pH is restored.
What types of vision problems could this technology treat?
Researchers are investigating the technique for refractive errors such as nearsightedness, farsightedness, and astigmatism. Early tests also suggest it might help reverse chemical-induced corneal cloudiness.
Is the electromechanical reshaping procedure currently available to patients?
Extensive animal testing and safety evaluations are required before human trials can begin.
Keep reading